Second, while current osteoporosis treatments encompass five major therapeutic options—bisphosphonates, selective estrogen receptor modulators, PTH analogs, RANKL inhibitors, and hormone replacement therapy—our review primarily focused on the two most commonly prescribed medications: RANKL inhibitors and bisphosphonates. Here, ESR1 is linked to osteoporosis.